https://www.live-feeds.com/feed/novo-nordisk-will-use-anthropic-s-claude-for-drug-researchContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/novo-nordisk-will-use-anthropic-s-claude-for-drug-researchhttps://www.live-feeds.com/feed/novo-nordisk-will-use-anthropic-s-claude-for-drug-research#u74288Fri, 18 Sep 2026 09:11:07 +0000Danish pharmaceutical company Novo Nordisk has formed a partnership with artificial intelligence lab Anthropic to utilize the Claude model and Claude Science tools for accelerating drug discovery and development. The collaboration aims to boost research and development productivity, shorten research timelines, and tackle complex challenges identified by Novo scientists and computational teams. Researchers intend to use the technology to analyze complex data sets, investigate human biology, and understand medication mechanisms. Additionally, Novo Nordisk stock surged 4 percent following the ann